Annual Immuno-Oncology Summit

11 August 202513 August 2025
Philadelphia, PAHilton Philadelphia at Penn’s Landing
Organized by Cambridge Healthtech Institute (CHI), this premier event brings together leading experts in the field to discuss the latest advancements and challenges in immuno-oncology.

The summit will feature a comprehensive program covering a wide range of topics, including:

  • Bi- and Multispecific Engineering: Exploring nanobody applications, functional bispecifics, target selection, and engineering for solid tumors.
  • Translating Multispecific Success: Combining multispecifics with cellular modalities, leveraging machine learning in development, addressing safety and regulatory hurdles, and insights from solid tumor clinical successes.
  • Antibody-Drug Conjugates (ADCs): Advancements in linker technologies, site-specific conjugation, overcoming resistance and toxicity, and enhancing targeting specificity.
  • Breakthroughs in Cell Therapy: Developments in CAR T therapy, TILs, TCRs, Tregs for solid tumors, combining multiple cell therapies, and reducing clinical attrition rates.
  • Autoimmunity: Applying immuno-oncology learnings to autoimmunity, B cell targeting, understanding the autoimmune microenvironment, and transient therapeutic approaches.
  • Innate Immunity: Insights into solid tumor biology, advancements in NK cell engagers and gamma delta developments, applications of machine learning and data science, and translatable models.